| Keenan Alhojerry Md Pllc | |
|
101 Shattuck Way Ste 2 Newington NH 03801-7876 | |
| (603) 433-8488 | |
| (603) 373-6009 |
| Full Name | Keenan Alhojerry Md Pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 101 Shattuck Way Ste 2, Newington, New Hampshire |
| Authorized Official Name and Position | Keenan Alhojerry (OWNER AND PROVIDER) |
| Authorized Official Contact | 6034338488 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Keenan Alhojerry Md Pllc Po Box 3160 Andover MA 01810-0803 Ph: (603) 433-8488 | Keenan Alhojerry Md Pllc 101 Shattuck Way Ste 2 Newington NH 03801-7876 Ph: (603) 433-8488 |
| NPI Number | 1720139017 |
|---|---|
| Provider Enumeration Date | 01/15/2007 |
| Last Update Date | 12/09/2022 |
| Medicare PECOS PAC ID | 1557683133 |
|---|---|
| Medicare Enrollment ID | O20141210001089 |
News Archive
For the first time, researchers from the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have characterized the brain's responses to vagus nerve stimulation (VNS) at various states of sleep and wakefulness.
In a study conducted to examine the health outcomes related to salt intake, as gauged by the amount of sodium excreted in the urine, lower sodium excretion was associated with an increased risk of cardiovascular death, while higher sodium excretion did not correspond with increased risk of hypertension or cardiovascular disease complications, according to a study in the May 4 issue of JAMA.
Research from The Cancer Institute of New Jersey (CINJ) shows that women with triple-negative breast cancer and no more than three positive lymph nodes following a mastectomy have a higher risk of local recurrence than similar women whose disease is not classified as triple-negative.
GENova Biotherapeutics, Inc., ("GENova"), is pleased to announce that it has filed a patent for a novel peptide that disrupts the advance of prostate cancer and thus has blockbuster potential as a new anti-cancer drug.
FASgen has announced that it has been awarded an SBIR grant from National Cancer Institute for refinement of its serum FAS (fatty acid synthase) ELISA cancer diagnostic test, FAS- Detect ELISA.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720139017 | NPI | - | NPPES |
| 30212410 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Keenan M Al-hojerry |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1063468981 PECOS PAC ID: 4880613132 Enrollment ID: I20051115001121 |
News Archive
For the first time, researchers from the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have characterized the brain's responses to vagus nerve stimulation (VNS) at various states of sleep and wakefulness.
In a study conducted to examine the health outcomes related to salt intake, as gauged by the amount of sodium excreted in the urine, lower sodium excretion was associated with an increased risk of cardiovascular death, while higher sodium excretion did not correspond with increased risk of hypertension or cardiovascular disease complications, according to a study in the May 4 issue of JAMA.
Research from The Cancer Institute of New Jersey (CINJ) shows that women with triple-negative breast cancer and no more than three positive lymph nodes following a mastectomy have a higher risk of local recurrence than similar women whose disease is not classified as triple-negative.
GENova Biotherapeutics, Inc., ("GENova"), is pleased to announce that it has filed a patent for a novel peptide that disrupts the advance of prostate cancer and thus has blockbuster potential as a new anti-cancer drug.
FASgen has announced that it has been awarded an SBIR grant from National Cancer Institute for refinement of its serum FAS (fatty acid synthase) ELISA cancer diagnostic test, FAS- Detect ELISA.
› Verified 1 days ago
News Archive
For the first time, researchers from the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have characterized the brain's responses to vagus nerve stimulation (VNS) at various states of sleep and wakefulness.
In a study conducted to examine the health outcomes related to salt intake, as gauged by the amount of sodium excreted in the urine, lower sodium excretion was associated with an increased risk of cardiovascular death, while higher sodium excretion did not correspond with increased risk of hypertension or cardiovascular disease complications, according to a study in the May 4 issue of JAMA.
Research from The Cancer Institute of New Jersey (CINJ) shows that women with triple-negative breast cancer and no more than three positive lymph nodes following a mastectomy have a higher risk of local recurrence than similar women whose disease is not classified as triple-negative.
GENova Biotherapeutics, Inc., ("GENova"), is pleased to announce that it has filed a patent for a novel peptide that disrupts the advance of prostate cancer and thus has blockbuster potential as a new anti-cancer drug.
FASgen has announced that it has been awarded an SBIR grant from National Cancer Institute for refinement of its serum FAS (fatty acid synthase) ELISA cancer diagnostic test, FAS- Detect ELISA.
› Verified 1 days ago
Au Blanc Nh Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Shattuck Way Ste 3, Newington, NH 03801 Phone: 603-431-4601 | |
Woodbury Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Shattuck Way, Suite 6, Newington, NH 03801 Phone: 603-430-0060 Fax: 866-835-8949 | |
Appledore Medical Group Do Not Use Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Shattuck Way, Newington, NH 03801 Phone: 603-929-9724 | |
Dba Mark Henschke Do Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2064 Woodbury Ave, Suite 102, Newington, NH 03801 Phone: 603-766-8130 Fax: 603-766-8131 |